Organic sales grew 1.7%, but Skin Health and Beauty saw a 2.7% decline in sales. For 2025, Kenvue projects organic sales growth of 2% to 4% and a potential operating margin increase. Kenvue posted ...

SKILLMAN, N.J., February 05, 2025--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) ("Kenvue"), the world’s largest pure-play consumer health company by revenue, today issued the following statement in ...

Kenvue (KVUE) issued the following statement in response to Starboard Value’s submission of four nominees to stand for election to the Kenvue Board of Directors at Kenvue’s 2025 Annual Meeting ...

Kenvue's stock has underperformed since its IPO, with disappointing guidance cuts for 2023 and 2024, and minimal growth projected for 2025. Despite recent struggles, Kenvue's strong brand ...

Feb 5 (Reuters) - Starboard Value has nominated four directors to the board of consumer products maker Kenvue (KVUE.N), opens new tab, months after the activist investor criticized lackluster ...

Bas Vorsteveld will oversee Kenvue’s Northern Europe business in the UK, Ireland, Norway, Sweden, Denmark and Finland, across a portfolio of iconic brands including Nicorette®**, Aveeno®, Johnson’s® ...

On Monday, William Blair reaffirmed a Market Perform rating on Kenvue Inc (NYSE:KVUE), a consumer health company with a market capitalization of $38.69 billion. According to InvestingPro data ...

Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today issued the following statement in response to Starboard Value’s (“Starboard ...

Kenvue Stock Up 2.2 % Shares of NYSE:KVUE opened at $20.23 on Friday. The firm has a market capitalization of $38.79 billion, a PE ratio of 36.78, a price-to-earnings-growth ratio of 2.05 and a ...

(Reuters) -Starboard Value has nominated four directors to the board of consumer products maker Kenvue, months after the activist investor criticized lackluster performance in a core segment.